NATALIE trial – Ribociclib – Tiny IDFS and imbalanced censoring | Why the trial is flawed



Vinay Prasad, MD MPH; Physician & Professor Hematologist/ Oncologist Professor of Epidemiology, Biostatistics and Medicine …

source

Tags: 271976271976271976271976271976271976271976
wpChatIcon
    wpChatIcon